Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 75.8 Million shares, which have been reported (via 13F filing form) to have a value of $797 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
170,533
shares
|
$1.79 Million
0.08% of portfolio
|
Q2 2025
Added 638.72%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
155,536
shares
|
$1.63 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
151,502
shares
|
$1.59 Million
0.0% of portfolio
|
Q2 2025
Reduced 43.89%
|
|
Bank Of Montreal
Toronto, A6 |
Aug 05, 2025 Q2 2025 |
143,512
shares
|
$1.51 Million
0.0% of portfolio
|
Q3 2024
Added 36.35%
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
134,380
shares
|
$1.41 Million
0.0% of portfolio
|
Q2 2025
Added 25.57%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
130,274
shares
|
$1.37 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.19%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
123,242
shares
|
$1.3 Million
0.0% of portfolio
|
Q2 2025
Added 48.25%
|
|
Allostery Investments LP
Stamford, CT |
Aug 14, 2025 Q2 2025 |
120,119
shares
|
$1.26 Million
9.81% of portfolio
|
Q2 2025
Reduced 54.86%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
110,846
shares
|
$1.16 Million
0.0% of portfolio
|
Q2 2025
Reduced 92.46%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
104,007
shares
|
$1.09 Million
0.09% of portfolio
|
Q2 2023
New holding
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
100,576
shares
|
$1.06 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
100,000
shares
|
$1.05 Million
0.04% of portfolio
|
Q1 2024
Reduced 50.0%
|
|
Eam Investors, LLC
Solana Beach, CA |
Aug 12, 2025 Q2 2025 |
99,960
shares
|
$1.05 Million
0.12% of portfolio
|
Q2 2025
New holding
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
95,219
shares
|
$1 Million
0.0% of portfolio
|
Q2 2025
Added 643.61%
|
|
Kennondale Capital Management LLC
Richmond, VA |
Aug 12, 2025 Q2 2025 |
95,165
shares
|
$1 Million
0.62% of portfolio
|
Q2 2025
Reduced 53.06%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
91,392
shares
|
$960,529
0.0% of portfolio
|
Q2 2025
Added 58.39%
|
|
Hennion & Walsh Asset Management, Inc.
|
Aug 07, 2025 Q2 2025 |
56,831
shares
|
$597,293
0.02% of portfolio
|
Q2 2025
Reduced 31.72%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
54,069
shares
|
$568,265
0.0% of portfolio
|
Q1 2025
Reduced 2.76%
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Aug 14, 2025 Q2 2025 |
50,000
shares
|
$525,500
0.0% of portfolio
|
Q2 2025
Reduced 50.0%
|
|
Mariner, LLC
Overland Park, KS |
Aug 14, 2025 Q2 2025 |
48,668
shares
|
$511,500
0.0% of portfolio
|
Q2 2025
Reduced 4.4%
|
|
Jump Financial, LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
47,800
shares
|
$502,378
0.0% of portfolio
|
Q2 2025
New holding
|
|
Centiva Capital, LP
New York, NY |
Aug 13, 2025 Q2 2025 |
45,464
shares
|
$477,826
0.01% of portfolio
|
Q2 2025
Added 61.09%
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Aug 13, 2025 Q2 2025 |
42,929
shares
|
$451,183
0.0% of portfolio
|
Q2 2025
New holding
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
40,643
shares
|
$427,157
0.0% of portfolio
|
Q2 2025
Reduced 46.42%
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
38,101
shares
|
$400,441
0.0% of portfolio
|
Q2 2025
Added 12600.33%
|